Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

77
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
77
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

83
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
83
Decreased Body Temperature01:29

Decreased Body Temperature

694
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
694
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

69
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
69
Increased pulse rate01:17

Increased pulse rate

748
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
748
Methods of reducing fever01:22

Methods of reducing fever

753
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
753

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular and subcellular localization of the copper transporter CTR1 in human postmortem hippocampus and striatum.

Scientific reports·2026
Same author

Leveraging clinical decision support to minimize sedation gaps in patients receiving rocuronium for rapid sequence intubation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same author

Comparative Pulmonary Artery Pressure Response between Large-Bore Thrombectomy and Catheter-Directed Thrombolysis in Patients with Intermediate-High- and High-Risk Pulmonary Embolism.

Journal of vascular and interventional radiology : JVIR·2026
Same author

A Modified Delphi Consensus-Based Comprehensive Checklist and Angoff Standard for Assessment of Competency in Brain Death/Death by Neurologic Criteria Determination.

Critical care medicine·2026
Same author

Integrating Brain Imaging Volumetrics and Quantitative Pupillometry for Predicting Neurologic Deterioration after Large Hemispheric Stroke.

Neurocritical care·2026

Related Experiment Video

Updated: Sep 11, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.5K

Not All Temperature Control Is Equal: High-Quality Temperature Control Is Associated With Improved Outcomes Following

Rachel Beekman1, Christine Nguyen1, Yanhong Deng2

  • 1Department of Neurology, Yale School of Medicine, New Haven, CT.

Annals of Emergency Medicine
|August 16, 2025
PubMed
Summary
This summary is machine-generated.

High-quality temperature control after cardiac arrest significantly improves survival and neurologic outcomes. Optimizing temperature control initiation is crucial for better patient recovery and neuroprotection.

Keywords:
Out-of-hospital cardiac arrestOutcomesQualityTemperature control

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.4K
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.5K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.4K
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.1K

Area of Science:

  • Critical Care Medicine
  • Cardiology
  • Neurology

Background:

  • Temperature control is a critical intervention for cardiac arrest survivors, but optimal parameters remain unclear.
  • Defining and assessing the quality of temperature control initiation is essential for understanding its impact on patient outcomes.

Purpose of the Study:

  • To define high-quality temperature control initiation in out-of-hospital cardiac arrest (OHCA) survivors.
  • To evaluate the association between the quality of temperature control and clinical outcomes, including survival and neurologic function.

Main Methods:

  • Retrospective study of 421 OHCA patients treated with temperature control (2014-2024).
  • Quality score (0-6) based on time to device initiation and anti-shivering treatment within 6 hours.
  • Binarized quality into low (<3) and high (≥3); analyzed outcomes using logistic regression and propensity score weighting.

Main Results:

  • 46.1% of patients received high-quality temperature control.
  • High-quality group achieved target temperature faster (5.4 vs. 8.8 hours).
  • High-quality temperature control was associated with significantly improved survival (OR 2.05-2.75) and favorable neurologic outcomes (OR 1.94-2.13).

Conclusions:

  • High-quality temperature control initiation is linked to better survival and neurologic outcomes in OHCA patients.
  • The quality of temperature control implementation likely influences its neuroprotective benefits.
  • Further prospective, multicenter studies are needed to confirm these findings and refine temperature control protocols.